A new study has shown that Abilify is effective at preventing manic relapses in patients with bipolar I disorder. Researchers at Bristol-Myers Squibb say this new research provides strong support for the use of Abilify to help bipolar patients maintain mood stability.
Read moreAbilify is an atypical antipsychotic (which simply means it is a newer antipsychotic than the original group) which may be used to treat... Read more »
Hi guys! It has been awhile since we have done a medication review. One of our members spoke about taking Abilify and so I thought... Read more »
In October last year, the FDA approved Seroquel for treating bipolar depression. Currently, there are three medications on the market... Read more »
Yesterday, after a deliberate sabbatical, I put out my first Newsletter of the year. The theme was "treating bipolar depression." To... Read more »
The U.S. Food and Drug Administration has approved Abilify to treat bipolar I disorder in children. The drug can now be used to ease manic and mixed... Read more »
The U.S. Food and Drug Administration (FDA) has granted priority review status to an application for the use of Abilify in children who suffer from... Read more »
The U.S. Food and Drug Administration has given expanded approval for the use of Abilify in treating bipolar disorder. The drug can now be used as a... Read more »
Source: First DataBank
Generic Name: ARIPIPRAZOLE - ORAL Pronounced: (ay-ree-PIP-ray-zole) Uses Aripiprazole is used to treat certain mental/mood disorders (such as... Read more »
Long-term use of Abilify may help delay relapse in adults with Bipolar I disorder, a new study suggests. Researchers found that adults with this... Read more »